Company profile

Kenneth H. Globus
Incorporated in
Fiscal year end
IRS number

UG stock data



13 May 20
5 Jul 20
31 Dec 20


Company financial data Financial data

Quarter (USD) Mar 20 Dec 19 Sep 19 Jun 19
Revenue 3.32M 3.82M 3.32M 3.28M
Net income 790.31K 1.39M 1.07M 1.08M
Diluted EPS 0.17 0.31 0.23 0.23
Net profit margin 23.78% 36.38% 32.25% 32.90%
Operating income 1.31M 1.65M 1.28M 1.22M
Net change in cash -258.12K -746.27K 883.88K 411.45K
Cash on hand 790.19K 1.05M 1.79M 910.71K
Cost of revenue 1.39M 1.51M 1.39M 1.47M
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 13.6M 13.45M 12.97M 10.78M
Net income 4.76M 4.35M 3.84M 2.58M
Diluted EPS 1.04 0.95 0.84 0.56
Net profit margin 35.01% 32.37% 29.64% 23.95%
Operating income 5.4M 5.58M 5.24M 3.39M
Net change in cash 498.18K -174.59K 300.42K -656.19K
Cash on hand 1.05M 550.14K 724.72K 424.3K
Cost of revenue 5.66M 5.34M 5.3M 4.88M

Financial data from company earnings reports

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
5 Mar 20 Kenneth H Globus Common Stock Gift Dispose G No 0 8,000 0 1,334,853
20 May 19 Kenneth H Globus Common Stock Gift Dispose G No 0 5,600 0 1,350,853
26.5% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 33 36 -8.3%
Opened positions 1 2 -50.0%
Closed positions 4 2 +100.0%
Increased positions 9 6 +50.0%
Reduced positions 9 12 -25.0%
13F shares
Current Prev Q Change
Total value 30.59M 24.4M +25.3%
Total shares 1.22M 1.22M +0.0%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Renaissance Technologies 267.27K $3.86M -2.0%
GBL Gamco Investors, Inc. Et Al 147.8K $2.14M 0.0%
Vanguard 118.82K $1.72M +3.0%
Dimensional Fund Advisors 116.78K $1.69M 0.0%
NEU Neuberger Berman 105.8K $1.53M -7.8%
TETAB Teton Advisors 72.3K $1.05M 0.0%
Parthenon 71.27K $1.03M 0.0%
Rodgers Brothers 58.35K $843K +64.4%
Gabelli Funds 38K $549K 0.0%
United Capital Financial Advisers 31.79K $459K -1.5%
Largest transactions
Shares Bought/sold Change
Rodgers Brothers 58.35K +22.85K +64.4%
Wealth Quarterback 745 -12.92K -94.5%
UBS UBS 17.37K +10.84K +166.0%
NEU Neuberger Berman 105.8K -8.93K -7.8%
Renaissance Technologies 267.27K -5.53K -2.0%
MS Morgan Stanley 8.22K -4.55K -35.6%
Vanguard 118.82K +3.46K +3.0%
O'shaughnessy Asset Management 0 -3.26K EXIT
DB Deutsche Bank 3.83K -3.2K -45.5%
BLK BlackRock 26.47K +699 +2.7%

Financial report summary

Management Discussion
  • Net sales for the first quarter of 2020 increased by $142,596 (approximately 4%) as compared with the first quarter of 2019. The increase in sales for the three-month period ended March 31, 2020 was primarily attributable to an increase in sales of the Company’s pharmaceutical products and industrial products, which was partially offset by decreased sales of the Company’s medical products. Sales of the Company’s cosmetic ingredients did not materially change compared with the first quarter of 2019. The changes in the sales of the products in the Company’s different products lines were as follows:
  • The increases in cosmetic ingredients sales were partially offset by a decrease in sales to the Company’s three other marketing partners in Europe. Sales to the Company’s marketing partners in the UK, Italy and Switzerland decreased by a total of $50,349 (approximately 35%) compared with the first quarter of 2019. In addition, during the first quarter of 2019, the Company had sales to its former marketing partner in Korea of $13,979. The Company is no longer working with that former marketing partner, and has appointed ASI its marketing partner in Korea. In late 2019, the Company began transitioning the Korean business to ASI. In addition to the increases and decreases in sales attributable to the Company’s European marketing partners, there was an increase of $1,270 in direct sales to two cosmetic ingredient customers in the United States during the first quarter of 2020.
  • The sales fluctuations to the Company’s European marketing partners are the result of both the timing of customer orders as well as continuing competition from companies selling competitive products at lower prices, particularly a number of Asian manufacturers. This has resulted in a loss of some business in Europe to these less expensive products. As a result, from time to time the Company has adjusted its prices in order to retain or attract customers and be more competitive with some of the lower-priced products. Although there has been some impact on the Company’s profit margins on those sales, to date this impact has not been significant. The Company intends to continue to aggressively compete with these products whenever possible.
Content analysis ?
H.S. freshman Avg
New words: accurate, aimed, appointed, April, brought, commensurate, consulting, consumer, delayed, density, difficult, drop, duration, epidemic, essential, event, fewer, flow, fourth, fringe, fulfill, Governor, granted, ingredient, July, larger, longer, maintain, maintaining, mitigate, multiple, November, obsolescence, ongoing, organic, pandemic, participation, passed, permitted, predict, problem, project, projected, projection, pronouncement, proportionately, quantify, raw, reached, rebounding, regular, relief, reopen, resume, safeguarding, satisfied, schedule, service, shut, simplify, Simplifying, slower, slowly, spread, staggered, steep, strategic, temporary, uncertainly, upcoming, vast
Removed: amendment, arising, August, balance, classification, core, created, decline, depend, drafted, entitle, entitled, entity, equipment, estate, existing, finance, improve, increasing, January, launch, lease, lessee, low, modified, nonrecurring, objective, ordering, portion, practical, primary, principle, real, recognizing, retrospective, review, sheet, subsequently, transition, understand